For a commercial driver, treatment is not only a health decision. It sits inside a federal process with its own steps, its own gatekeeper and its own clock, and the sequence is not optional.
The rule that governs everything else is short. After a DOT drug or alcohol regulation violation, you cannot again perform any DOT safety-sensitive duties for any employer until and unless you complete the substance abuse professional evaluation, referral, and education or treatment process [1].
This page sets out what triggers that, who the substance abuse professional is, what follow-up testing looks like, what your employer is and is not told, and how to start quickly. None of it is legal advice, and an employment lawyer is the right person to apply any of it to a specific job.
DOT testing, the Clearinghouse and what a positive triggers
A violation is a defined event rather than a judgment call, and knowing the definition removes most of the guesswork.
It covers a verified positive, adulterated or substituted controlled substances test result, an alcohol confirmation test with a concentration of 0.04 or higher, and a refusal to test [3]. An employer’s report of actual knowledge of a violation counts too [3].
The federal testing panel is set by regulation rather than by the employer. It covers marijuana, cocaine, amphetamines, opioids and phencyclidine [4], which is why a driver using a prescription stimulant or an opioid painkiller needs that on record with the medical review officer rather than explained after the fact.
The Clearinghouse is what makes a violation follow a driver between jobs. Employers must query it before hiring, and must run at least one query a year for all employees subject to controlled substance and alcohol testing under the rule, to determine whether information exists about those employees [3]. There is a limited query that only indicates whether information exists, with a full query needed to release it [3].
That is the honest framing. Moving to a different carrier does not reset this. Our overview of addiction treatment covers the clinical side that sits underneath it.
Return-to-duty process and the substance abuse professional
The substance abuse professional, usually shortened to SAP, is the person who decides when the process is complete. Not the employer, and not the treatment program.
The sequence starts with the SAP evaluation, which is the first step in the mandated return-to-duty process [1]. From there the SAP makes a referral to education, treatment or both, and the driver completes what was recommended.
What that recommendation looks like varies with the assessment. It may be an education program, it may be a course of treatment at a particular level of care, and it may be both. Our explainer on levels of care sets out what each level involves so the SAP’s recommendation is legible when it arrives.
The part drivers most often get wrong is the order. Completing a program you chose yourself, before an evaluation, does not on its own satisfy the requirement: the regulation is written around the SAP’s evaluation, referral and education or treatment process [1]. Ask who the SAP is and book that evaluation first.
Follow-up testing schedules
Follow-up testing is not the same thing as random testing, and it runs on top of it.
The SAP writes it. For each employee who has committed a DOT drug or alcohol regulation violation, the SAP must establish a written follow-up testing plan [2].
There is a floor. The SAP must, at a minimum, direct that the employee be subject to six unannounced follow-up tests in the first 12 months of safety-sensitive duty following the return to safety-sensitive functions [2]. The SAP sets the number and frequency, decides whether the tests cover drugs, alcohol or both, and may require testing beyond that first year; the employer decides the actual dates [2].
Plan around it rather than being surprised by it. Unannounced means unannounced, and a driver who has thought about what a test day looks like mid-route is in a better position than one who has not.
Treatment timed around a return-to-duty plan
The useful question is not how long treatment takes in general. It is which level of care the SAP is likely to recommend and how quickly it can start.
Care sits on a continuum rather than in separate boxes [5]. Intensity follows need: the American Society of Addiction Medicine defines intensive outpatient treatment as 9 hours of treatment a week for adults [5], generally spread over 3 to 5 days [5], and TIP 47’s consensus panel recommends a range of 6 to 30 hours based on client needs [5].
For a driver, the scheduling matters as much as the hours. An intensive outpatient program built around several structured sessions a week is a different proposition from residential care, and which is appropriate is a clinical answer rather than a logistical one. Residential and inpatient care and outpatient rehab set out what each one asks of a week.
Where withdrawal needs medical management, that comes first. Medical detox is its own level of care, and whether it applies comes from the assessment rather than from a preference to get back on the road.
Stimulants, alcohol and life on the road
The substances that show up in this population are not random, and the federal panel is a fair map of what gets caught.
It tests for marijuana, cocaine, amphetamines, opioids and phencyclidine [4]. Amphetamines and cocaine are the stimulant end of that list, and the reason they appear on a driving page is obvious once stated: they are what people reach for to stay awake.
Alcohol sits in a separate rule with its own threshold, a confirmation test at 0.04 or higher [3]. That is lower than the limit most drivers know from ordinary road law, which is a detail worth holding onto.
Opioids are the third pattern, and they often start legitimately after a back injury or surgery. A prescription is not a defense on its own; it is something to route through the medical review officer before a test, not after one. Our page on who addiction affects covers how occupation shapes the picture.
Employer notification and what is required
Two separate systems are running here, and drivers routinely confuse them.
The first is the DOT process, and it is not confidential from the employer. Test results, violations and the Clearinghouse record exist precisely so that safety-sensitive work can be controlled, and employers are required to query the Clearinghouse before hiring and at least annually thereafter [3].
The second is your clinical record, and that is protected. Records covered by the federal substance use disorder confidentiality rule may be used or disclosed only as those rules permit [6], and disclosures outside the program generally need your written consent [7]. What a program tells your employer about the content of your treatment is governed by that rule and by what you sign.
The practical consequence is worth stating plainly. Assume the violation and the return-to-duty status are visible to an employer, and do not assume the clinical detail is. If a specific disclosure worries you, ask to see the release form before signing it and take legal advice if the stakes are your job.
Sleep, health and the physical toll
The job’s shape is part of the clinical picture, and a program that ignores it is planning for someone else.
Irregular hours, nights, time zones and sleeping away from home are the conditions the plan has to survive. So is eating badly and exercising rarely. None of that is a moral failing; it is the environment the return-to-duty plan gets executed in.
It also shapes what a realistic continuing-care plan looks like. A weekly appointment at a fixed time in one city is a poor fit for a long-haul schedule, and saying so early produces a better plan than discovering it in month two.
Raise the schedule on the first call rather than at discharge. Our page on what the treatment process is like covers the phases, and therapy approaches used in treatment covers what the sessions involve.
Getting evaluated fast to shorten time off
Time off work is the cost drivers actually feel, and the single biggest lever on it is how quickly the SAP evaluation happens.
Do three things in the first week. Find out who the SAP is and book the evaluation. Start a benefits check in parallel rather than after. And get your own account of the history straight, because the evaluation is only as good as what it is given.
Then let the sequence run in order: evaluation, referral, the education or treatment that was recommended, and the follow-up testing plan that comes with the return [1][2]. Skipping ahead does not shorten it.
Cost is the other obstacle. A plan that covers substance use disorder benefits may not apply tighter financial requirements or treatment limits to that care than to medical and surgical benefits [8]. Those rules reach limits such as prior authorization [8]. Parity has a scope worth knowing. It applies to non-federal governmental plans with more than 50 employees, to private employer group plans with more than 50 employees, and to individual-market coverage [8]. Small-employer group plans are generally outside it, though non-grandfathered small-group and individual plans must cover mental health and substance use disorder services as an essential health benefit under the Affordable Care Act [8]. Our pages on insurance coverage for rehab, what treatment costs and how admission works explain the terms, our directory of campuses lists each campus with its levels and its city, and our treatment centers page groups them by state. Medication, where it is part of the plan, is covered on our medication-assisted treatment page and is a conversation for the treating clinician and the medical review officer together.
Frequently Asked Questions
Does a program I complete before the SAP evaluation count? Not on its own. After a DOT drug or alcohol regulation violation you cannot perform any DOT safety-sensitive duties for any employer until and unless you complete the substance abuse professional evaluation, referral, and education or treatment process. Find out who the SAP is and book that evaluation first, then follow the referral it produces. Admissions can tell you which groups and schedules are running at a campus once you know what was recommended.
Will my employer or licensing body be told? Treat the two systems separately. The DOT side is not private from an employer: employers must query the Clearinghouse before hiring and at least once a year for covered employees. Your clinical record is different. Records covered by the federal confidentiality rule may be used or disclosed only as those rules permit, and disclosures outside the program generally need your written consent.
How many follow-up tests should I expect when I go back? At least six. For each employee who has committed a DOT drug or alcohol regulation violation, the substance abuse professional must establish a written follow-up testing plan, and must at a minimum direct that the employee be subject to six unannounced follow-up tests in the first 12 months of safety-sensitive duty after returning. The SAP sets the number and frequency, decides whether the tests cover drugs, alcohol or both, and may require testing beyond that first year; the employer decides the actual dates.
Is the DOT alcohol threshold the same as the roadside limit? No, and the gap catches drivers out. A violation includes an alcohol confirmation test with a concentration of 0.04 or higher, which is lower than the limit most drivers know from ordinary road law. Alcohol sits in its own rule, separate from the drug panel, which covers marijuana, cocaine, amphetamines, opioids and phencyclidine. A refusal to test is a violation in its own right too.
Does moving to a different carrier clear a violation? No. The Clearinghouse is what makes a violation follow a driver between jobs. Employers must query it before hiring, and must run at least one query a year for all employees subject to controlled substance and alcohol testing under the rule, to determine whether information exists about those employees. There is a limited query that only indicates whether information exists, with a full query needed to release it.
Sources
- Legal Information Institute. 49 CFR § 40.285 — When is a SAP evaluation required? Cornell Law School. https://www.law.cornell.edu/cfr/text/49/40.285
- Legal Information Institute. 49 CFR § 40.307 — What is the SAP’s function in prescribing the employee’s follow-up tests? Cornell Law School. https://www.law.cornell.edu/cfr/text/49/40.307
- Legal Information Institute. 49 CFR § 382.701 — Drug and Alcohol Clearinghouse. Cornell Law School. https://www.law.cornell.edu/cfr/text/49/382.701
- Legal Information Institute. 49 CFR § 40.85 — Which drugs do laboratories test for? Cornell Law School. https://www.law.cornell.edu/cfr/text/49/40.85
- Center for Substance Abuse Treatment. (2006). Substance Abuse: Clinical Issues in Intensive Outpatient Treatment — Chapter 3, Intensive Outpatient Treatment and the Continuum of Care. Treatment Improvement Protocol (TIP) Series No. 47, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64088/
- Legal Information Institute. 42 CFR § 2.13 — Confidentiality restrictions and safeguards. Cornell Law School. https://www.law.cornell.edu/cfr/text/42/2.13
- Legal Information Institute. 42 CFR § 2.31 — Consent requirements. Cornell Law School. https://www.law.cornell.edu/cfr/text/42/2.31
- Centers for Medicare & Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity
This page is for general information and is not medical advice, and it is not legal advice about your employment or your license. Only a licensed clinician who knows your history can tell you what is right for you, and an employment lawyer is the right person to apply the federal rules described here to your own job. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
